The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Arteriovenous Malformations Market Increase Between 2026 And 2030?
The arteriovenous malformations market size has demonstrated significant expansion in recent years. It is anticipated to increase from $3.1 billion in 2025 to $3.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. The market’s past growth is attributable to enhancements in neuroimaging technologies, heightened clinical awareness of avm conditions, the proliferation of specialized neurosurgical centers, the adoption of endovascular embolization techniques, and the expansion of hospital-based neurological care.
The market for arteriovenous malformations is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $4.37 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.1%. Several factors are expected to fuel this growth during the projection period, including a heightened need for accurate diagnostics, greater financial input into neurovascular studies, a wider embrace of minimally invasive treatments, a stronger emphasis on individualized treatment strategies, and a broader supply of sophisticated interventional tools. Key developments expected within this timeframe involve a greater uptake of cutting-edge neuroimaging diagnostic methods, an increased application of minimally invasive endovascular therapies, a heightened priority on timely and precise diagnosis, the broadening of diverse treatment methodologies, and improved oversight of patient results after treatment.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21888&type=smp
What Major Growth Factors Are Impacting The Arteriovenous Malformations Market?
The arteriovenous malformations market is expected to grow, driven by the increasing preference for minimally invasive procedures. These surgical or therapeutic methods employ small incisions or catheter-based approaches to minimize trauma, shorten recovery periods, and reduce complications. The rising demand for these procedures is linked to their faster recovery times, as smaller incisions cause less tissue damage and accelerate healing. This allows patients to return to their daily routines more quickly compared to traditional open surgeries, making them a favored option for both patients and healthcare providers. Arteriovenous malformations (AVMs) benefit from minimally invasive techniques, such as endovascular embolization, which utilizes catheters and image-guided interventions to correct abnormal blood flow without requiring open surgery, thereby lowering risks, reducing recovery times, and improving patient outcomes. For example, data from the American Society of Plastic Surgeons in September 2023 showed that 25,442,640 cosmetic minimally invasive procedures were performed in the US in 2023, an increase from 23,672,269 procedures in 2022, signifying a 7% growth in minimally invasive treatments across both genders in 2023. Consequently, the growing demand for minimally invasive procedures is fueling the expansion of the arteriovenous malformations market.
Arteriovenous Malformations Market Driver: Increasing Investment In Biotechnology Fueling The Growth Of The Market Due To Advancements In Arteriovenous Malformations Treatment And Neurovascular Innovations
What Key Segment Areas Are Included In The Arteriovenous Malformations Market Assessment?
The arteriovenous malformations market covered in this report is segmented –
1) By Type: True Arteriovenous Malformation, Occult Or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Other Types
2) By Diagnosis: Physical examination, Brain Scans, Other Diagnosis
3) By Treatment: Endovascular Embolization, Neurosurgery
4) By Age Group: Adult Patients, Pediatric Patients
5) By End-User: Hospitals And Clinics, Research laboratories, Other End-Users
Subsegments:
1) By True Arteriovenous Malformation: Pial AVMs, Spinal AVMs, Brain AVMs, Extremity AVMs, Visceral AVMs
2) By Occult or Cryptic: Micro-AVMs, Hidden AVMs, Asymptomatic AVMs, Deep-Seated AVMs, Small-Scale AVMs
3) By Cavernous Malformations: Cerebral Cavernous Malformations (CCMs), Spinal Cavernous Malformations, Familial Cavernous Malformations, Solitary Cavernous Malformations, Multiple Cavernous Malformations
4) By Venous Malformation: Superficial Venous Malformations, Deep Venous Malformations, Mixed Venous Malformations, Syndromic Venous Malformations, Blue Rubber Bleb Nevus Syndrome
5) By Hemangioma: Infantile Hemangiomas, Capillary Hemangiomas, Lobular Capillary Hemangiomas, Cavernous Hemangiomas, Compound Hemangiomas
6) By Dural Fistula: Cranial Dural Arteriovenous Fistula (dAVF), Spinal Dural Arteriovenous Fistula, Direct Dural AV Fistula, Indirect Dural AV Fistula, High-Flow Dural Fistula
7) By Other Types: Lymphatic Malformations, Mixed Vascular Malformations, Arteriovenous Aneurysms, Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs, Rare Congenital AVMs
Which Trends Are Contributing To Changes In The Arteriovenous Malformations Market?
Major companies in the arteriovenous malformations market are concentrating on technological innovations, such as liquid embolic system procedural sets, to improve treatment procedures and patient outcomes. A liquid embolic system procedural set is a pre-assembled, sterilized kit containing essential components for delivering liquid embolic agents to treat vascular abnormalities like arteriovenous malformations (AVMs). For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set features two configurations and the necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, optimizing procedure preparation for treating cerebral arteriovenous malformations (AVMs).
Who Are The Prominent Players Across The Arteriovenous Malformations Market?
Major companies operating in the arteriovenous malformations market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Terumo Corporation, Penumbra Inc, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc, Balt LLC, Shape Memory Medical Inc, MicroVention Inc, Cerenovus, Brainlab AG, Boston Scientific Corporation, Abbott Laboratories, B Braun Melsungen AG, Siemens Healthineers AG, GE Healthcare Technologies Inc, Koninklijke Philips NV, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation
Access The Complete Arteriovenous Malformations Market Report:
https://www.thebusinessresearchcompany.com/report/arteriovenous-malformations-global-market-report
Which Region Commands The Largest Share Of The Arteriovenous Malformations Market?
North America was the largest region in the arteriovenous malformations market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriovenous malformations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Arteriovenous Malformations Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=21888&type=smp
Browse Through More Reports Similar to the Global Arteriovenous Malformations Market 2026, By The Business Research Company
Vascular Imaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report
Giant Cell Arteritis Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/giant-cell-arteritis-global-market-report
Vascular Stent Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model